ArticleAmerican journal of translational research2017
Subcutaneous liraglutide ameliorates methylglyoxal-induced Alzheimer-like tau pathology and cognitive impairment by modulating tau hyperphosphorylation and glycogen synthase kinase-3β.
Liqin Qi et al.PubMed ↗Full text ↗
No numbers read from the abstract.
22 papers cite it
this papercites it